Thinq Drug Discovery Private Limited - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2011.
2011 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Thinq Drug Discovery Private Limited

Thinq Drug Discovery Private Limited, a struck off private limited company, was established on 01 April 2011 in Mumbai, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24233MH2011PTC215633. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Uday Purushottam Ohale (Director), Sameer Shripad Wagh (Director). Past directors included Murlidhar Narayan Chaini. Its latest AGM occurred on 30 September 2013, with the balance sheet filed on 31 March 2013. It is based at Flat No 14, Plot No 63, Indraini Apartment, Cheda Nagar, Chembur, Mumbai, Maharashtra, 400089.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233MH2011PTC215633

  • Registration Number

    215633

  • Incorporation Date

    01 April 2011

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 11 Months
  • Last Filing with ROC 31 Mar 2013
Company report

Thinq Drug Discovery Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Thinq Drug Discovery Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Thinq Drug Discovery Private Limited?
Current Directors
Name Designation Appointment Date Status
Uday Purushottam Ohale Director 01 Apr 2011 Current
Sameer Shripad Wagh Director 01 Apr 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 26 Feb 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Thinq Drug Discovery.

Enhance accessibility to Thinq Drug Discovery's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Thinq Drug Discovery revenue growth over time
Thinq Drug Discovery profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Thinq Drug Discovery?

Unlock access to Thinq Drug Discovery's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Thinq Drug Discovery?

Unlock and access historical data on people associated with Thinq Drug Discovery, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Thinq Drug Discovery, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thinq Drug Discovery's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Thinq Drug Discovery
Recent Activity within the Organization
  • Annual General Meeting

    The activity Thinq Drug Discovery Private Limited last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records. was completed.

  • Balance Sheet

    Thinq Drug Discovery Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    The activity Uday Purushottam Ohale was appointed as a Director was appointed as a Director on 01 Apr 2011 & has been associated with this company since 14 years 11 months . was completed.

  • Director Appointment

    The activity Sameer Shripad Wagh was appointed as a Director was appointed as a Director on 01 Apr 2011 & has been associated with this company since 14 years 11 months . was completed.

  • Company Incorporation

    Progress on Thinq Drug Discovery Private Limited was registered on 01 Apr 2011 with Roc Mumbai & aged 14 years 11 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Thinq Drug Discovery Private Limited?

The CIN of Thinq Drug Discovery Private Limited is U24233MH2011PTC215633.

Where is Thinq Drug Discovery Private Limited headquartered?

Thinq Drug Discovery Private Limited is headquartered at Flat No 14, Plot No 63, Indraini Apartment, Cheda Nagar, Chembur, Mumbai, Maharashtra, 400089.

When was Thinq Drug Discovery Private Limited incorporated?

Thinq Drug Discovery Private Limited was incorporated on 01 April 2011.

Who are the current directors of Thinq Drug Discovery Private Limited?

The current directors of Thinq Drug Discovery Private Limited are

What is the primary industry of Thinq Drug Discovery Private Limited?

The primary industry of Thinq Drug Discovery Private Limited is Chemicals.

Is Thinq Drug Discovery Private Limited a listed company?

Thinq Drug Discovery Private Limited is unlisted.

What is the capital structure of Thinq Drug Discovery Private Limited?

The authorized capital of Thinq Drug Discovery Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available